The N-ICE trial: A randomised controlled trial of the safety and efficacy of N-Acetyl Cysteine (NAC) as a pharmacotherapy for methamphetamine (“ice”) dependence [ 2017 - ]

Research Grant

Researchers: A/Pr Rebecca McKetin (Principal investigator) ,  A/Pr Peter Kelly ,  Dr Alyna Turner ,  Dr Brendan Quinn ,  Dr Olivia Dean
View all 9 related researchers

Brief description Crystalline methamphetamine (aka ‘ice’) is a significant public health concern in Australia and globally. Currently there are no approved medications to treat methamphetamine dependence. We will trial tN-acetyl-cysteine (NAC) as a medications for methamphetamine dependence.

Funding Amount $1,551,368.00

Funding Scheme Project Grants

Notes Standard Project Grant